
Honored to share our Optimize PRO study at #EuroPCR, highlighted by @JACCJournals. Largest collaborative evaluation of implantation depth in #TAVR. Higher Evolut implantation was linked to a 2.3% 1-year pacemaker rate, improved valve function in men, and no added safety concerns














